1. Abdul-Ghani RA, Loutfy N, Hassan A (2009) Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use. Parasitol Res 105:899–906
2. Albuquerque MCPA, Silva TG, Pitta MG, Silva AC, Silva PG, Malagueño E, Santana JV, Wanderley AG, Lima MC, Galdino SL, Barbe J, Pitta IR (2005) Synthesis and schistosomicidal activity of new substituted thioxo-imidazoline compounds. Die Pharmazie 60:13–17
3. Albuquerque MCPA, Pitta MG, Irmão JI, Peixoto CA, Malagueño E, Santana JV, Lima MC, Galdino SL, Pitta IR (2007) Tegumental alterations in adult Schistosoma mansoni treated with imidazolidine derivatives. Lat Am J Pharm 26:65–69
4. Andrade ZA (2005) Regressão da fibrose hepática. Rev Soc Bras Med Trop 38:514–520
5. Andrade ZA, Cheever AW (1993) Charecterization of the murine modelo schistosomal hepática periportal fibrosis (“pipestem” fibrosis). Int J Exp Pathol 74:95–202